Yazmin San Miguel1, Joshua Demb2, Maria Elena Martinez3, Samir Gupta4, Folasade P May5. 1. Division of Gastroenterology, Department of Medicine, Veterans Affairs San Diego Healthcare System, San Diego, California; Moores Cancer Center and Department of Family Medicine and Public Health, University of California San Diego, La Jolla, California. 2. Division of Gastroenterology, Department of Internal Medicine, University of California San Diego, La Jolla, California. 3. Moores Cancer Center and Department of Family Medicine and Public Health, University of California San Diego, La Jolla, California. 4. Division of Gastroenterology, Department of Medicine, Veterans Affairs San Diego Healthcare System, San Diego, California; Division of Gastroenterology, Department of Internal Medicine, University of California San Diego, La Jolla, California. Electronic address: s1gupta@ucsd.edu. 5. Division of Gastroenterology, Department of Medicine, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California; Vatche and Tamar Manoukian Division of Digestive Diseases and Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, California. Electronic address: fmay@mednet.ucla.edu.
Abstract
BACKGROUND AND AIMS: The optimal time interval for diagnostic colonoscopy completion after an abnormal stool-based colorectal cancer (CRC) screening test is uncertain. We examined the association between time to colonoscopy and CRC outcomes among individuals who underwent diagnostic colonoscopy after abnormal stool-based screening. METHODS: We performed a retrospective cohort study of veterans age 50 to 75 years with an abnormal fecal occult blood test (FOBT) or fecal immunochemical test (FIT) between 1999 and 2010. We used multivariable Cox proportional hazards to generate CRC-specific incidence and mortality hazard ratios (HRs) and 95% confidence intervals (CI) for 3-month colonoscopy intervals, with 1 to 3 months as the reference group. Association of time to colonoscopy with late-stage CRC diagnosis was also examined. RESULTS: Our cohort included 204,733 patients. Mean age was 61 years (SD 6.9). Compared with patients who received a colonoscopy at 1 to 3 months, there was an increased CRC risk for patients who received a colonoscopy at 13 to 15 months (HR 1.13; 95% CI 1.00-1.27), 16 to 18 months (HR 1.25; 95% CI 1.10-1.43), 19 to 21 months (HR 1.28; 95% CI: 1.11-1.48), and 22 to 24 months (HR 1.26; 95% CI 1.07-1.47). Compared with patients who received a colonoscopy at 1 to 3 months, mortality risk was higher in groups who received a colonoscopy at 19 to 21 months (HR 1.52; 95% CI 1.51-1.99) and 22 to 24 months (HR 1.39; 95% CI 1.03-1.88). Odds for late-stage CRC increased at 16 months. CONCLUSIONS: Increased time to colonoscopy is associated with higher risk of CRC incidence, death, and late-stage CRC after abnormal FIT/FOBT. Interventions to improve CRC outcomes should emphasize diagnostic follow-up within 1 year of an abnormal FIT/FOBT result. Published by Elsevier Inc.
BACKGROUND AND AIMS: The optimal time interval for diagnostic colonoscopy completion after an abnormal stool-based colorectal cancer (CRC) screening test is uncertain. We examined the association between time to colonoscopy and CRC outcomes among individuals who underwent diagnostic colonoscopy after abnormal stool-based screening. METHODS: We performed a retrospective cohort study of veterans age 50 to 75 years with an abnormal fecal occult blood test (FOBT) or fecal immunochemical test (FIT) between 1999 and 2010. We used multivariable Cox proportional hazards to generate CRC-specific incidence and mortality hazard ratios (HRs) and 95% confidence intervals (CI) for 3-month colonoscopy intervals, with 1 to 3 months as the reference group. Association of time to colonoscopy with late-stage CRC diagnosis was also examined. RESULTS: Our cohort included 204,733 patients. Mean age was 61 years (SD 6.9). Compared with patients who received a colonoscopy at 1 to 3 months, there was an increased CRC risk for patients who received a colonoscopy at 13 to 15 months (HR 1.13; 95% CI 1.00-1.27), 16 to 18 months (HR 1.25; 95% CI 1.10-1.43), 19 to 21 months (HR 1.28; 95% CI: 1.11-1.48), and 22 to 24 months (HR 1.26; 95% CI 1.07-1.47). Compared with patients who received a colonoscopy at 1 to 3 months, mortality risk was higher in groups who received a colonoscopy at 19 to 21 months (HR 1.52; 95% CI 1.51-1.99) and 22 to 24 months (HR 1.39; 95% CI 1.03-1.88). Odds for late-stage CRC increased at 16 months. CONCLUSIONS: Increased time to colonoscopy is associated with higher risk of CRC incidence, death, and late-stage CRC after abnormal FIT/FOBT. Interventions to improve CRC outcomes should emphasize diagnostic follow-up within 1 year of an abnormal FIT/FOBT result. Published by Elsevier Inc.
Authors: Adriano Correia; Linda Rabeneck; Nancy N Baxter; Lawrence F Paszat; Rinku Sutradhar; Lingsong Yun; Jill Tinmouth Journal: Prev Med Date: 2015-04-18 Impact factor: 4.018
Authors: Jessica Chubak; Michael P Garcia; Andrea N Burnett-Hartman; Yingye Zheng; Douglas A Corley; Ethan A Halm; Amit G Singal; Carrie N Klabunde; Chyke A Doubeni; Aruna Kamineni; Theodore R Levin; Joanne E Schottinger; Beverly B Green; Virginia P Quinn; Carolyn M Rutter Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-02 Impact factor: 4.254
Authors: Lasse Kaalby; Morten Rasmussen; Erik Zimmermann-Nielsen; Magdalena Maria Buijs; Gunnar Baatrup Journal: Clin Epidemiol Date: 2019-07-30 Impact factor: 4.790
Authors: Chyke A Doubeni; Nicole B Gabler; Cosette M Wheeler; Anne Marie McCarthy; Philip E Castle; Ethan A Halm; Mitchell D Schnall; Celette S Skinner; Anna N A Tosteson; Donald L Weaver; Anil Vachani; Shivan J Mehta; Katharine A Rendle; Stacey A Fedewa; Douglas A Corley; Katrina Armstrong Journal: CA Cancer J Clin Date: 2018-03-30 Impact factor: 508.702
Authors: Ari Bell-Brown; Lisa Chew; Bryan J Weiner; Lisa Strate; Bryan Balmadrid; Cara C Lewis; Peggy Hannon; John M Inadomi; Scott D Ramsey; Rachel B Issaka Journal: Front Health Serv Date: 2022-01-17
Authors: Elaine C Khoong; Natalie A Rivadeneira; Lucia Pacca; Dean Schillinger; David Lown; Palav Babaria; Neha Gupta; Rajiv Pramanik; Helen Tran; Tyler Whitezell; Ma Somsouk; Urmimala Sarkar Journal: J Gen Intern Med Date: 2022-05-31 Impact factor: 6.473
Authors: Rachel B Issaka; Ari Bell-Brown; Jason Kao; Cyndy Snyder; Dana L Atkins; Lisa D Chew; Bryan J Weiner; Lisa Strate; John M Inadomi; Scott D Ramsey Journal: Prev Med Rep Date: 2022-05-18
Authors: Joshua Demb; Lin Liu; Ranier Bustamante; Jason A Dominitz; Ashley Earles; Shailja C Shah; Andrew J Gawron; Maria Elena Martinez; Samir Gupta Journal: Dig Dis Sci Date: 2022-09-28 Impact factor: 3.487
Authors: Ashley C Mog; Peter S Liang; Lucas M Donovan; George G Sayre; Aasma Shaukat; Folasade P May; Thomas J Glorioso; Michelle A Jorgenson; Gordon Blake Wood; Candice Mueller; Jason A Dominitz Journal: Clin Transl Gastroenterol Date: 2022-02-01 Impact factor: 4.396